Opportunity Information: Apply for PA 20 068
The Agency for Health Care Research and Quality (AHRQ) is offering a discretionary research grant opportunity titled "Improving Quality of Care and Patient Outcomes During Care Transitions (R01)" under Funding Opportunity Number PA 20 068 (CFDA 93.226). This FOA supports health services research projects that go beyond describing problems and instead rigorously test interventions designed to improve communication and coordination when patients move between care settings, such as from hospital to home, hospital to skilled nursing facilities, or between different clinical teams and providers. The overall aim is to generate strong evidence on what actually works to make transitions safer and more effective, with the expectation that better coordination and clearer communication will translate into improved patient outcomes and quality of care.
The focus of the work is on care transitions, which are widely recognized as high-risk moments for patients because information can be lost, responsibilities can be unclear, follow-up plans may not be completed, and medication or treatment changes can be misunderstood. Through an R01 mechanism, the FOA is looking for robust, methodologically sound studies that test "promising interventions" rather than exploratory concepts alone. In practical terms, this implies research designs that can credibly measure impact, such as controlled trials, well-constructed quasi-experimental designs, or other rigorous evaluation approaches appropriate to real-world health care settings. Projects should be positioned to assess whether an intervention improves coordination processes (for example, handoffs, discharge planning, information transfer, and accountability) and whether those process improvements lead to meaningful patient-centered outcomes.
Eligibility is broad and includes many types of U.S.-based organizations and governments. Eligible applicants include state, county, and city or township governments; special district governments; independent school districts; public and state-controlled institutions of higher education; private institutions of higher education; Native American tribal governments (federally recognized); public housing authorities/Indian housing authorities; Native American tribal organizations other than federally recognized tribal governments; nonprofit organizations with and without 501(c)(3) IRS status (as long as they are not institutions of higher education in that nonprofit category); for-profit organizations other than small businesses; small businesses; and other organizations as allowed by the FOA. The announcement also explicitly notes additional eligible applicant types, including faith-based or community-based organizations, eligible federal government agencies, and a range of minority-serving institutions such as Historically Black Colleges and Universities (HBCUs), Hispanic-serving institutions, Tribal Colleges and Universities (TCCUs), Alaska Native and Native Hawaiian Serving Institutions, and Asian American Native American Pacific Islander Serving Institutions (AANAPISISs). Regional organizations and U.S. territories or possessions are also included among the entities that may apply.
At the same time, the FOA sets clear limits related to foreign participation. Non-domestic (non-U.S.) entities (foreign institutions) are not eligible to apply, and non-domestic components of U.S. organizations are also not eligible. While the text mentions "Non-domestic (non-U.S.) Entities (Foreign Organizations)" in the list of "other eligible applicants," it then explicitly states that foreign institutions are not eligible to apply and that non-U.S. components of U.S. organizations are not eligible. The practical takeaway is that the applicant organization must be domestic, and the work supported under this FOA must not be carried out through non-U.S. organizational components.
Key administrative details included in the source information are that the funding instrument type is a grant and the activity category is health. The FOA was created on 2019-12-04, and an original closing date listed is 2022-12-06. The provided source data does not specify an award ceiling or the expected number of awards, so applicants would need to consult the full FOA text for budget expectations, project period limits, review criteria, and any specific topic priorities or required outcome measures. Overall, the opportunity is aimed at building practical, generalizable evidence for interventions that make transitions of care more coordinated, more communicative, and ultimately safer for patients.Apply for PA 20 068
- The Agency for Health Care Research and Quality in the health sector is offering a public funding opportunity titled "Improving Quality of Care and Patient Outcomes During Care Transitions (R01)" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.226.
- This funding opportunity was created on 2019-12-04.
- Applicants must submit their applications by 2022-12-06. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- Eligible applicants include: State governments, County governments, City or township governments, Special district governments, Independent school districts, Public and State controlled institutions of higher education, Native American tribal governments (Federally recognized), Public housing authorities/Indian housing authorities, Native American tribal organizations (other than Federally recognized tribal governments), Nonprofits having a 501 (c) (3) status with the IRS, other than institutions of higher education, Nonprofits that do not have a 501 (c) (3) status with the IRS, other than institutions of higher education, Private institutions of higher education, For-profit organizations other than small businesses, Small businesses, Others.
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Frequently Asked Questions (FAQs)
1) What is the name of this funding opportunity?
The opportunity is titled "Improving Quality of Care and Patient Outcomes During Care Transitions (R01)."
2) Which agency is offering this grant?
The Agency for Health Care Research and Quality (AHRQ) is offering this discretionary research grant opportunity.
3) What is the Funding Opportunity Number (FON) for this announcement?
The Funding Opportunity Number is PA 20 068.
4) What is the CFDA number associated with this opportunity?
The CFDA number listed is 93.226.
5) What type of funding instrument is being offered?
The funding instrument type is a grant.
6) What is the activity category for this opportunity?
The activity category is health.
7) What mechanism does this FOA use (and what does that imply)?
This FOA uses an R01 mechanism, and it is looking for robust, methodologically sound studies that rigorously test promising interventions (rather than only describing problems or presenting purely exploratory concepts).
8) What is the main purpose of this FOA?
The FOA supports health services research projects that test interventions designed to improve communication and coordination when patients move between care settings or care teams, with the goal of producing strong evidence about what works to make transitions safer and more effective.
9) What is meant by "care transitions" in this announcement?
Care transitions refer to patients moving between care settings or providers, such as from hospital to home, hospital to skilled nursing facilities, or between different clinical teams and providers.
10) Why are care transitions a focus area for research?
Care transitions are described as high-risk moments because information can be lost, responsibilities can be unclear, follow-up plans may not be completed, and medication or treatment changes can be misunderstood.
11) What kind of projects does AHRQ want to fund under this FOA?
AHRQ is seeking projects that go beyond describing problems and instead rigorously test interventions aimed at improving communication and coordination during transitions of care.
12) Does this FOA support purely descriptive studies?
Based on the provided information, the FOA emphasizes research that goes beyond describing problems and focuses on rigorously testing interventions. That suggests purely descriptive studies would not align with the stated intent.
13) What does the FOA mean by "promising interventions"?
In practical terms, "promising interventions" are approaches that can be rigorously evaluated using credible designs in real-world health care settings, rather than early-stage ideas that are not yet ready for strong impact testing.
14) What study designs are implied to be a good fit for this FOA?
The FOA implies the use of rigorous evaluation approaches such as controlled trials, well-constructed quasi-experimental designs, or other methodologically sound designs appropriate to real-world health care settings.
15) What outcomes or impacts should projects be positioned to assess?
Projects should be positioned to assess whether an intervention improves coordination processes (for example, handoffs, discharge planning, information transfer, and accountability) and whether those improvements lead to meaningful patient-centered outcomes, improved patient outcomes, and improved quality of care.
16) What are examples of coordination processes mentioned in the FOA?
Examples listed include handoffs, discharge planning, information transfer, and accountability.
17) What kinds of transition settings are specifically mentioned?
The FOA specifically mentions transitions such as hospital to home, hospital to skilled nursing facilities, and transitions between different clinical teams and providers.
18) Who is eligible to apply?
Eligibility is broad and includes many U.S.-based organizations and governments. Examples include state, county, and city or township governments; special district governments; independent school districts; public and state-controlled institutions of higher education; private institutions of higher education; Native American tribal governments (federally recognized); public housing authorities/Indian housing authorities; Native American tribal organizations other than federally recognized tribal governments; nonprofit organizations with and without 501(c)(3) IRS status (with the noted limitation that certain nonprofit categories must not be institutions of higher education); for-profit organizations other than small businesses; small businesses; and other organizations as allowed by the FOA.
19) Are faith-based or community-based organizations eligible?
Yes. The announcement explicitly notes that faith-based or community-based organizations are included among eligible applicant types.
20) Are federal government agencies eligible?
Yes. The announcement explicitly notes eligible federal government agencies among additional eligible applicant types.
21) Are minority-serving institutions (MSIs) eligible to apply?
Yes. The FOA explicitly references a range of minority-serving institutions, including Historically Black Colleges and Universities (HBCUs), Hispanic-serving institutions, Tribal Colleges and Universities (TCCUs), Alaska Native and Native Hawaiian Serving Institutions, and Asian American Native American Pacific Islander Serving Institutions (AANAPISISs).
22) Are U.S. territories or possessions eligible to apply?
Yes. U.S. territories or possessions are included among the entities that may apply.
23) Are regional organizations eligible?
Yes. Regional organizations are mentioned as included among the entities that may apply.
24) Are non-U.S. (foreign) organizations eligible to apply?
No. The FOA states that non-domestic (non-U.S.) entities (foreign institutions) are not eligible to apply.
25) Can a U.S. organization apply if the work will be carried out by a non-U.S. component?
No. The FOA explicitly states that non-domestic components of U.S. organizations are not eligible.
26) Why is there potential confusion about foreign eligibility in the text?
The provided information notes that while foreign organizations appear in an "other eligible applicants" list, the FOA then explicitly states that foreign institutions are not eligible and that non-U.S. components of U.S. organizations are not eligible. The practical takeaway given is that the applicant must be domestic and the supported work must not be carried out through non-U.S. organizational components.
27) When was this FOA created?
The FOA was created on 2019-12-04.
28) What is the original closing date listed for this opportunity?
An original closing date listed is 2022-12-06.
29) Does the provided information list an award ceiling?
No. The provided source data does not specify an award ceiling.
30) Does the provided information state the expected number of awards?
No. The provided source data does not specify the expected number of awards.
31) Does the provided information include budget expectations or project period limits?
No. The provided information says applicants would need to consult the full FOA text for budget expectations, project period limits, review criteria, and any specific topic priorities or required outcome measures.
32) What is the overarching goal of the research supported by this FOA?
The overarching goal is to build practical, generalizable evidence for interventions that make transitions of care more coordinated and communicative, thereby making care safer and improving patient outcomes and quality of care.
Browse more opportunities from the same category: Health
Next opportunity: Revision Applications for Incorporation of Novel NCI-Supported Technology to Accelerate Cancer Research (R01 Clinical Trial Optional)
Previous opportunity: Limited Competition: Competitive Supplement to the Coordinating Center for Type 1 Diabetes TrialNet (U01 Clinical Trial Required)
Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for PA 20 068
Applicants also applied for:
Applicants who have applied for this opportunity (PA 20 068) also looked into and applied for these:
| Funding Opportunity |
|---|
| Immune Tolerance Network (UM1 Clinical Trial Required) Apply for RFA AI 19 068 Funding Number: RFA AI 19 068 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Advanced-Stage Development and Utilization of Research Infrastructure for Interdisciplinary Aging Studies (R33 Clinical Trial Optional) Apply for PAR 20 071 Funding Number: PAR 20 071 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Research Infrastructure Development for Interdisciplinary Aging Studies (R21/R33 - Clinical Trial Optional) Apply for PAR 20 070 Funding Number: PAR 20 070 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| National Dental Practice-Based Research Network Infrastructure Access (X01 Clinical Trial Not Allowed) Apply for PAR 20 073 Funding Number: PAR 20 073 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| NIAID Investigator Initiated Program Project Applications (P01 Clinical Trial Not Allowed) Apply for PAR 20 072 Funding Number: PAR 20 072 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| NIDCR Predoctoral to Postdoctoral Transition Award for A Diverse Dental, Oral, and Craniofacial Research Workforce (F99/K00 Clinical Trial Not Allowed) Apply for PAR 20 069 Funding Number: PAR 20 069 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| CATALYTIC CHANGE FOR CROSS BORDER HEALTH Apply for RFI 720 623 001 Funding Number: RFI 720 623 001 Agency: Kenya USAID-Nairobi Category: Health Funding Amount: $10,000,000 |
| Novel Imaging Approaches for detection of Persistent HIV and Neuroimmune dysfunction associated with HIV In the Central Nervous System (CNS) (R21 Clinical Trial Not Allowed) Apply for RFA MH 20 331 Funding Number: RFA MH 20 331 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Novel Imaging Approaches for detection of Persistent HIV and Neuroimmune dysfunction associated with HIV In the Central Nervous System (CNS) (R01 Clinical Trial Optional) Apply for RFA MH 20 330 Funding Number: RFA MH 20 330 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Glial Plasticity in the Aging Brain (R01 Clinical Trial Not Allowed) Apply for RFA AG 21 010 Funding Number: RFA AG 21 010 Agency: National Institutes of Health Category: Health Funding Amount: $250,000 |
| Mechanisms of Rejuvenation and Age-Acceleration in Heterochronic Blood Exchange (R01 Clinical Trial Not Allowed) Apply for RFA AG 21 002 Funding Number: RFA AG 21 002 Agency: National Institutes of Health Category: Health Funding Amount: $300,000 |
| Novel Therapeutics Directed to Intracellular HIV Targets (R21 Clinical Trial Not Allowed) Apply for RFA AI 19 072 Funding Number: RFA AI 19 072 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Secondary Analysis of Existing Datasets in Heart, Lung, and Blood Diseases and Sleep Disorders (R21 Clinical Trial Not Allowed) Apply for PAR 20 078 Funding Number: PAR 20 078 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Limited Competition 4DN Data Coordination and Integration Center (U01 Clinical Trial Not Allowed) Apply for RFA RM 20 008 Funding Number: RFA RM 20 008 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Limited Competition: 4DN Organizational Hub (U01 Clinical Trial Not Allowed) Apply for RFA RM 20 007 Funding Number: RFA RM 20 007 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Surgical Disparities Research (R01 - Clinical Trial Optional) Apply for PAR 20 079 Funding Number: PAR 20 079 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| NIBIB Trailblazer Award for New and Early Stage Investigators (R21 Clinical Trial Optional) Apply for PAR 20 084 Funding Number: PAR 20 084 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Development and Application of PET and SPECT Imaging Ligands as Biomarkers for Drug Discovery and for Pathophysiological Studies of CNS Disorders (R01 Clinical Trial Not Allowed) Apply for PAR 20 037 Funding Number: PAR 20 037 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Animal and Biological Material Resource Centers (P40) (Clinical Trials Not-Allowed) Apply for RFA OD 20 002 Funding Number: RFA OD 20 002 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Development and Application of PET and SPECT Imaging Ligands as Biomarkers for Drug Discovery and for Pathophysiological Studies of CNS Disorders (R01 Clinical Trial Optional) Apply for PAR 20 038 Funding Number: PAR 20 038 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Inside Our Applicants Portal
Access Applicants Portal
- Grants Repository - Access current and historic funding opportunities with ease. Thousands of funding opportunities are published every week. We can help you sort through the database and find the eligible ones to apply for.
- Applicant Video Guides - The grant application process can be challenging to follow. We can help you with intuitive video guides to speed up the process and eliminate errors in submissions.
- Grant Proposal Wizard - We have developed a network of private funding organizations and investors across the United States. We can reach out and submit your proposal to these contacts to maximize your chances of getting the funding you need.
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Learn More
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "PA 20 068", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.
